This activity is designed to inform physicians about the latest treatment advances and data in less common lymphomas, focusing on the field of Hodgkin lymphoma and T-cell lymphoma, including both recently approved and investigational treatment strategies
Instructions For This Activity & Receiving Credit
|
This activity is directed toward hematologists, medical oncologists, nurses, and nurse practitioners who manage and treat patients with lymphoma. Transplantation specialists, radiation oncologists, pathologists, fellows, physician assistants, and other healthcare providers interested in the treatment of lymphoma are also invited to participate.
David Lee, PhD
Disclosure: No relevant financial relationships with commercial interests to disclose.
Debu Tripathy, MD
Professor of Medicine and Chair
Department of Breast Medical Oncology
The University of Texas MD Anderson Cancer Center
Houston, TX
Disclosure: Grant/research support from Genentech/Roche, Pfizer, Puma Inc, and Novartis (clinical trial support contracted to the University of Southern California and MD Anderson Cancer Center); consultant for Eisai, Oncoplex Diagnostics, Merck, and Novartis.
Steven Horwitz, MD
Memorial Sloan Kettering Cancer Center
New York, NY
Disclosure: No relevant financial relationships with commercial interests to disclose.
The staff of Physicians' Education Resource®, LLC (PER®) and the editorial staff of The American Journal of Hematology/Oncology® have no relevant financial relationships with commercial interests to disclose.
In accordance with Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial SupportSM, PER® resolved all conflicts of interest (COI) prior to the release of this CME activity using a multistep process.
Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Physicians' Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity is funded by Physicians' Education Resource®, LLC.
This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options for a specific patient’s medical condition.